Progression-free survival in diffuse large B cell lymphoma patients in... | Download Scientific Diagram
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
![PDF] Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/910db6912e5f808721d987fcdb285a61b2b6afb3/2-Table1-1.png "PDF] Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. | Semantic Scholar")
PDF] Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. | Semantic Scholar
Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma | BMC Cancer | Full Text
Survival analysis in patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Diffuse Large B-Cell Lymphoma | NEJM
Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy | Annals of Hematology
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
About RITUXAN® (rituximab) | Diffuse Large B Cell Lymphoma
RELB AS A NOVEL PROGNOSTIC BIOMARKER FOR DIFFUSE LARGE B-CELL LYMPHOMA ( DLBCL) | ERGANEO
Diffuse Large B Cell Lymphoma - an overview | ScienceDirect Topics
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study - eBioMedicine
Disease-free survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen | Journal of Nuclear Medicine
Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China - Wei Wang, Jingjing Yin, Wei Zhang, Yan Zhang,
Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
The overall survival of in diffuse large B‐cell lymphoma (DLBCL)... | Download Scientific Diagram
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study | Haematologica
![PDF] Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51a4a761ac9c47aeab4203b78043f3c50a5bbe83/2-Table1-1.png "PDF] Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. | Semantic Scholar")